Clinical Trial Update: Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. [Phase 3]

View source ↗

Summary

Phase 3 international adaptive platform trial in Europe evaluating two RSV prevention options—maternal vaccine during pregnancy and an infant monoclonal antibod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Nirsevimat (nirsevimat)
• RSV maternal vaccine

Snippet

Sponsor: PENTA Foundation | Conditions: RSV Immunization | Phase 3 | Status: NOT_YET_RECRUITING